Kits Eyecare Reports Preliminary Second Quarter 2026 Results, Spotlights Growth

Published on July 10, 2026
VANCOUVER, B.C.—Kits Eyecare Ltd. (TSX: KITS), a leading vertically integrated eyecare provider based in Canada, has announced selected preliminary unaudited results for its second quarter ended June 30, 2026. In making the announcement, the company reported a preliminary total unaudited revenue of approximately $58.2 million, an increase of 17.3 percent year-over-year compared with the same period in 2025. Kits advised it intends to report its full second quarter 2026 results in early August with details for the second quarter conference call to be disclosed in the coming weeks.
Continue reading on website
Other news

UN-TI-TLED’s Nico Roseillier Hosts Eyewear Design and Manufacturing Lecture at NECO

July 10, 2026
BOSTON—Nico Roseillier, founder and creative director of UN-TI-TLED creative studio, led a guest lecture for more than 120 second year students at the New England College of Optometry (NECO) on July 6. Titled “Storydesign Through Eyewear and Manufacturing,” the lecture traced eyewear’s arc from trend research to sketching, manufacturing, packaging, retail design and the in-store experience as one

Tarsus Pharmaceuticals Acquires iRenix Medical, Developer of Late-Stage Ocular Antiseptic IRX-101

July 10, 2026
IRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a biopharmaceutical company focused on therapeutic eyecare, has announced the acquisition of iRenix Medical, Inc., a privately held, clinical-stage ophthalmic biopharmaceutical company and developer of IRX-101, an investigational ocular antiseptic with the potential to reduce post-procedural pain and corneal toxicity in patients receiving